VOR BIOPHARMA INC (VOR) Stock Balance Sheet
NASDAQ:VOR - Nasdaq - US9290331084 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 50.05M | 81.95M | 31.36M | 57.70M | 119.80M | |||
| Marketable Securities | 9.99M | 9.98M | 105.81M | 172.50M | 87.70M | |||
| Other Current Assets | 4.81M | 4.58M | 3.63M | 6.70M | 6.90M | |||
| Total Current Assets | 64.85M | 96.51M | 140.80M | 237.00M | 214.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 39.68M | 41.59M | 50.10M | 57.10M | 22.50M | |||
| Other Non-Current Assets | 4.78M | 4.80M | 7.22M | 5.30M | 5.70M | |||
| Total Non-Current Assets | 44.47M | 46.38M | 57.32M | 62.40M | 28.20M | |||
| TOTAL ASSETS | 109.31M | 142.89M | 198.13M | 299.40M | 242.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.95M | 17.11M | 14.71M | 11.20M | 8.20M | |||
| Accounts Payable | 3.73M | 1.50M | 815.00K | 1.80M | 1.50M | |||
| Other Current Liabilities | 44.00K | 0.00 | 50.00K | 200.00K | 400.00K | |||
| Total Current Liabilities | 16.73M | 18.61M | 15.57M | 13.10M | 10.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 26.52M | 27.61M | 31.83M | 35.60M | 16.20M | |||
| Total Non-Current Liabilities | 26.52M | 27.61M | 31.83M | 35.70M | 16.10M | |||
| TOTAL LIABILITIES | 43.24M | 46.23M | 47.40M | 48.80M | 26.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -489.48M | -456.99M | -340.08M | -222.20M | -130.10M | |||
| Additional Paid In Capital | 555.51M | 553.62M | 490.87M | 473.60M | 346.40M | |||
| Common Shares | 13.00K | 13.00K | 7.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 124.85M | 124.78M | 67.89M | 66.00M | 37.20M | |||
| Tangible Book Value per Share | 0.53 | 0.77 | 2.22 | 3.80 | 5.81 | |||
| Total Shareholders' Equity | 66.07M | 96.66M | 150.72M | 250.60M | 216.30M | |||
| TOTAL LIABILITIES AND EQUITY | 109.31M | 142.89M | 198.13M | 299.40M | 242.60M | |||
| Statistics | ||||||||
| Current Ratio | 3.88 | 5.19 | 9.04 | 18.09 | 21.02 | |||
| Return On Assets (ROA) | -108.49% | -81.82% | -59.49% | -30.76% | -28.91% | |||
| Return On Equity (ROE) | -179.50% | -120.95% | -78.20% | -36.75% | -32.42% | |||
All data in USD , ROIC based on taxRate of 0.21